Design of Experiments Approach for the Development of a Validated UPLC-Q-ToF/MS Method to Quantitate Soy-Derived Bioactive Peptide Lunasin in Rabbit Plasma: Application to a Pharmacokinetic Study
{"title":"Design of Experiments Approach for the Development of a Validated UPLC-Q-ToF/MS Method to Quantitate Soy-Derived Bioactive Peptide Lunasin in Rabbit Plasma: Application to a Pharmacokinetic Study","authors":"Gullapalli Kowmudi, Karthika Anoop, Magham Sai Varshini, Krishnaveni Nagappan, Sreenath Konanki, Thaggikuppe Krishnamurthy Praveen","doi":"10.1002/bmc.70098","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>A novel ultraperformance liquid chromatography coupled with quadrupole time-of-flight mass spectrometric (UPLC-Q-ToF/MS) method for quantifying soy-derived bioactive peptide lunasin in rabbit plasma was developed using design of experiments (DoE) methodology. Lunasin and Neuropeptide Y as an internal standard (IS) were separated on a BEH-C18 column (50 mm × 2.1 mm, 1.7 μm particle size) using 0.1% formic acid solution and acetonitrile as mobile phase delivered for 9 min at a constant flow rate of 0.4 mL/min in gradient mode. The Q-ToF mass spectrometer, equipped with electrospray combined ionization (ESCi) interface, was operated in positive ion mode, and the quantifier ions of lunasin and IS were at <i>m</i>/<i>z</i> 838 and <i>m</i>/<i>z</i> 602, respectively. The lower limit of quantification (LLOQ) was 34.6 ng/mL, and the assay was linear over the concentration range 35–10,000 ng/mL. The accuracy was within a range from 86.7% to 88.9% in terms of mean recovery (<i>R</i>), and the intraday and interday precisions in terms of relative standard deviation (RSD) were < 2.65% and < 6.22%, respectively. The method was successfully applied to a pharmacokinetic study involving oral administration of lunasin-rich processed soybeans (6.56 and 19.1 g/kg) to rabbits.</p>\n </div>","PeriodicalId":8861,"journal":{"name":"Biomedical Chromatography","volume":"39 6","pages":""},"PeriodicalIF":1.8000,"publicationDate":"2025-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomedical Chromatography","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/bmc.70098","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0
Abstract
A novel ultraperformance liquid chromatography coupled with quadrupole time-of-flight mass spectrometric (UPLC-Q-ToF/MS) method for quantifying soy-derived bioactive peptide lunasin in rabbit plasma was developed using design of experiments (DoE) methodology. Lunasin and Neuropeptide Y as an internal standard (IS) were separated on a BEH-C18 column (50 mm × 2.1 mm, 1.7 μm particle size) using 0.1% formic acid solution and acetonitrile as mobile phase delivered for 9 min at a constant flow rate of 0.4 mL/min in gradient mode. The Q-ToF mass spectrometer, equipped with electrospray combined ionization (ESCi) interface, was operated in positive ion mode, and the quantifier ions of lunasin and IS were at m/z 838 and m/z 602, respectively. The lower limit of quantification (LLOQ) was 34.6 ng/mL, and the assay was linear over the concentration range 35–10,000 ng/mL. The accuracy was within a range from 86.7% to 88.9% in terms of mean recovery (R), and the intraday and interday precisions in terms of relative standard deviation (RSD) were < 2.65% and < 6.22%, respectively. The method was successfully applied to a pharmacokinetic study involving oral administration of lunasin-rich processed soybeans (6.56 and 19.1 g/kg) to rabbits.
期刊介绍:
Biomedical Chromatography is devoted to the publication of original papers on the applications of chromatography and allied techniques in the biological and medical sciences. Research papers and review articles cover the methods and techniques relevant to the separation, identification and determination of substances in biochemistry, biotechnology, molecular biology, cell biology, clinical chemistry, pharmacology and related disciplines. These include the analysis of body fluids, cells and tissues, purification of biologically important compounds, pharmaco-kinetics and sequencing methods using HPLC, GC, HPLC-MS, TLC, paper chromatography, affinity chromatography, gel filtration, electrophoresis and related techniques.